Epaderm®

Gentle care for sensitive skin

Buy Now

0
Would recommend¹
0
Years trusted
0
Ages suitable

Dry skin relief for the whole family

A kinder treatment for sensitive skin conditions such as eczema and psoriasis. Free from fragrance, colours, Sodium Lauryl Sulphate (SLS) and steroids. Suitable for all ages, including babies.

Two expert formulas, one trusted brand

Epaderm® Cream
2-in-1 Emollient & Skin Cleanser

A clinically proven water-based emollient that effectively relieves dry skin symptoms, improving hydration and smoothness after just two weeks². Lightweight, non-greasy and fast-absorbing, perfect for daily use on the whole family.
Improves hydration within 2 weeks (clinically proven)²

Non-greasy, absorbs quickly

Twist-and-lock pump dispenser

Contains plant-based Glycerine for moisture retention

Free from fragrance, colours, SLS, parabens & steroids

Suitable for all ages, including babies

Available in 50g and 500g sizes
Buy Epaderm® Cream
Epaderm® Ointment
3-in-1 Emollient, Cleanser & Bath Additive

A thicker, more occlusive formula for moderate to severe dry skin conditions. Used as a direct skin emollient, skin cleanser, and bath additive³, ideal for overnight use.
- 3-in-1: emollient, cleanser & bath additive
- Occlusive barrier prevents moisture loss
- Recommended for moderate to severe conditions
- Contains Liquid Paraffin & Yellow Soft Paraffin
- Free from fragrance, colours, SLS & steroids
Available in 125g, 500g and 1kg
Buy Epaderm® Ointment

Epaderm® Junior

The Epaderm Junior range utilises the tried-and-tested formulations of our standard Epaderm Cream and Epaderm Ointment products, with the addition of fun and friendly packaging designs, to help parents in motivating their children to have emollients applied.

Designed with children in mind
Easy to use
Rich & hydrating
Suitable for all ages
Supports skin health

Epaderm Junior Cream is available in 50g and 150g sizes. Epaderm Junior Ointment is avaiable in 125g.

Buy Epaderm® Junior

What can Epaderm® help with?

Eczema

Eczema (also called atopic dermatitis) is one of the most common inflammatory skin conditions in Australia, affecting up to one in three children⁴ and one in ten adults⁵. It is a chronic, relapsing condition, but with the right skincare routine, most people can manage it effectively and live comfortably.
Psoriasis

Psoriasis affects around 2–3% of Australians⁶ which is approximately 520,000 people. It is a chronic autoimmune condition that causes the skin to renew itself far too quickly, leading to a build-up of cells that form itchy, scaly patches. While there is currently no cure, psoriasis can be managed very effectively with the right combination of emollient therapy, lifestyle adjustments and, where needed, medical treatment.
Dry Skin

Dry skin (medically known as xerosis) is the most common skin complaint seen by healthcare professionals⁷. It can range from mildly rough or flaky skin to severely cracked, painful skin that bleeds or becomes infected. Fortunately, it is also one of the most treatable skin conditions, with consistent emollient use at its core.

Backed by clinical science

Epaderm® Cream is the subject of peer-reviewed clinical research, demonstrating significant improvements in skin hydration, softness and xerosis across all age groups, from infants to adults².

A prospective clinical investigation assessed the performance and efficacy of Epaderm® Cream in patients with dry skin conditions. Significant improvements were observed in patient-reported skin moisturisation, softness, and clinical measurements of xerosis². Published in Clinical, Cosmetic and Investigational Dermatology.

Download a summary of the clinical study here

References

1. August S, Granier S, Tighe M, Tbaily L. A prospective clinical investigation of Epaderm® Cream to confirm the performance and safety in adult and paediatric patients with eczema, psoriasis and other dry skin conditions. 2020.
2. Waring M et al. An investigation of the effect of six emollients on skin characteristics. Journal of the Dermatology Nurses’ Association. 2014;6(1):33-41.
3. Cork MJ, Complete Emollient Therapy. The National Association of Fundholding Practices Official Yearbook. BPC Waterlow, Dunstable 1998: 159-168.
4. Murdoch Children's Research Institute. Eczema [Internet]. Melbourne: MCRI; [cited 2026 May 21]. Available from: https://www.mcri.edu.au/a-z-child-health/d-f/eczema.
5. Zeleke BM, Dharmage SC, Lopez DJ, Koplin JJ, Peters RL, et al. Epidemiology of eczema in South-Eastern Australia. Australas J Dermatol. 2023;64:e41–e50. doi:10.1111/ajd.13966.
6. Foley P, Baker C, Carey W, Cooper A, Gebauer K, Gupta M, et al. Australian consensus: treatment goals for moderate to severe psoriasis in the era of targeted therapies. Australas J Dermatol. 2023;64:e238–e246. doi:10.1111/ajd.14138.
7. Paul C, Maumus-Robert S, Mazereeuw-Hautier J, Guyen CN, Saudez X, Schmitt AM. Prevalence and risk factors for xerosis in the elderly: a cross-sectional epidemiological study in primary care. Dermatology. 2011;223(3):260–265. doi:10.1159/000334631.